zolpidem has been researched along with Cancer of Mouth in 1 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Incidence rates of all cancers and selected site-specific cancers were measured by the end of 2009, and related hazard ratios (HRs) and 95% confidence intervals (CIs) of the cancer were measured as well." | 1.38 | Relationship of zolpidem and cancer risk: a Taiwanese population-based cohort study. ( Chang, SN; Kao, CH; Liang, JA; Muo, CH; Sun, LM; Sung, FC, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kao, CH | 1 |
| Sun, LM | 1 |
| Liang, JA | 1 |
| Chang, SN | 1 |
| Sung, FC | 1 |
| Muo, CH | 1 |
1 other study available for zolpidem and Cancer of Mouth
| Article | Year |
|---|---|
Relationship of zolpidem and cancer risk: a Taiwanese population-based cohort study.
Topics: Adult; Breast Neoplasms; Cohort Studies; Confidence Intervals; Esophageal Neoplasms; Female; Humans; | 2012 |